Literature DB >> 3437624

The effect of oral adsorbent on surgically induced hepatic failure.

M Hiraishi1.   

Abstract

The oral adsorbent AST-120 is one type of activated carbon for oral use. In the present study, AST-120 was administered, to clarify its effect, on surgically induced hepatic failure in dogs and rats. Portacaval shunts and varying extents of hepatectomies were performed on 44 dogs. Eleven dogs were given an ordinary diet (control group), and 33 dogs received the oral adsorbent with an ordinary diet after the operation (AST group). Plasma bile acids and ammonia increased, and body weight decreased in both groups. However, after the administration of AST-120, the plasma bile acids and ammonia decreased significantly, and the body weight tended to increase in the AST group. Portacaval shunts and about 70 per cent hepatectomy were performed on 59 Sprague-Dawley rats. These rats were divided into two groups, diet with the oral adsorbent (AST group, n = 19) and an ordinary diet alone (control group, n = 40). DNA synthesis and protein synthesis of the liver were measured on the 5th, 10th and 20th postoperative days using radioisotopes in these rats. Both DNA and protein synthesis of the liver were increased significantly in the AST group. Histological examination revealed many more glycogen granules in the cytoplasm of hepatocytes in the AST group compared to the control group on the 5th postoperative day. It was suggested that some metabolic toxin was adsorbed by AST-120 in the alimentary tract.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3437624     DOI: 10.1007/BF02470756

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  9 in total

1.  Hepatotrophic effects of pancreatic and gastrointestinal hormones in the rat in vivo and in vitro.

Authors:  U Junge; W Creutzfeldt
Journal:  Ciba Found Symp       Date:  1977

2.  Charcoal haemoperfusion in the treatment of fulminant hepatic failure.

Authors:  B G Gazzard; M J Weston; I M Murray-Lyon; H Flax; C O Record; R Williams; B Portmann; P G Langley; E H Dunlop; P J Mellon; M B Ward
Journal:  Lancet       Date:  1974-06-29       Impact factor: 79.321

3.  Presence of hepatocyte-specific mitotic inhibitor in normal rat plasma.

Authors:  H Onda; J Yoshikawa
Journal:  Gan       Date:  1973-04

4.  Effect of an oral adsorbent on chronic hepatic disturbance.

Authors:  T Takahama; Z Yamazaki; I Iizuka; F Kanai; M Hiraishi; T Wada; Y Fujimori; K Asano; K Koide; N Inoue
Journal:  Trans Am Soc Artif Intern Organs       Date:  1983

5.  Effect of autonomic denervation on DNA synthesis during liver regeneration after partial hepatectomy.

Authors:  H Kato; T Shimazu
Journal:  Eur J Biochem       Date:  1983-08-15

6.  Surgically induced acute hepatic failure in the rat.

Authors:  M Minato; D Houssin; J Morin; A M Szekely; H Bismuth
Journal:  Eur Surg Res       Date:  1982       Impact factor: 1.745

7.  Hepatic regeneration in the absence of portal viscera.

Authors:  A D Whittemore; M Kasuya; A B Voorhees; J B Price
Journal:  Surgery       Date:  1975-03       Impact factor: 3.982

8.  The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes.

Authors:  R D Hughes; A M Cochrane; A D Thomson; I M Murray-Lyon; R Williams
Journal:  Br J Exp Pathol       Date:  1976-06

9.  Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat liver by serum from patients with fulminant hepatic failure.

Authors:  C D Gove; R D Hughes; R Williams
Journal:  Br J Exp Pathol       Date:  1982-10
  9 in total
  3 in total

Review 1.  Novel Drugs for the Management of Hepatic Encephalopathy: Still a Long Journey to Travel.

Authors:  Siddheesh Rajpurohit; Balaji Musunuri; Pooja Basthi Mohan; Shiran Shetty
Journal:  J Clin Exp Hepatol       Date:  2022-01-31

Review 2.  Hepatic encephalopathy: an updated approach from pathogenesis to treatment.

Authors:  Giannakis T Toris; Christos N Bikis; Gerasimos S Tsourouflis; Stamatios E Theocharis
Journal:  Med Sci Monit       Date:  2011-02

Review 3.  Contributions of microdialysis to new alternative therapeutics for hepatic encephalopathy.

Authors:  Liliana Rivera-Espinosa; Esaú Floriano-Sánchez; José Pedraza-Chaverrí; Elvia Coballase-Urrutia; Aristides Iii Sampieri; Daniel Ortega-Cuellar; Noemí Cárdenas-Rodríguez; Liliana Carmona-Aparicio
Journal:  Int J Mol Sci       Date:  2013-08-05       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.